Godavari Drugs (530317.BO) Stock Price
Godavari Drugs Price
Revenue has compounded at 18.8% per year over the past 19 years to 1.06 B INR. Earnings per share have grown at 46.4% per year over the last 15 years. Godavari Drugs's net margin stands at 3.9%, broadly stable from 3.3% several years earlier.
Godavari Drugs stock price
Godavari Drugs business model & stock analysis
Frequently asked questions about Godavari Drugs
Converted at the current exchange rate, the Godavari Drugs share trades at 1.29 EUR (140.00 INR).
The revenue of Godavari Drugs is 1.06 B INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Godavari Drugs is 40.89 M INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Godavari Drugs is currently 34.67. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Godavari Drugs stock.
The price-to-sales ratio (P/S) of Godavari Drugs is currently 1.34. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Godavari Drugs stock.
The Eulerpool Quality Score for Godavari Drugs is 4/10.
The ISIN of Godavari Drugs is INE362C01012. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Godavari Drugs is 530317.BO. The ticker symbol is used to trade Godavari Drugs shares on the stock exchange.
Godavari Drugs stock
Godavari Drugs Peer Group
Godavari Drugs FIGI
All fundamentals and in-depth analysis of Godavari Drugs
Our stock analysis for Godavari Drugs stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Godavari Drugs. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.